NCT06618118 - A Study to Assess Adverse Events of Fosigotifator (ABBV-CLS-7262) in Adults With Major Depressive Disorder | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 23, 2024

Primary Completion Date

September 23, 2025

Study Completion Date

September 23, 2025

Conditions

Major Depressive Disorder (MDD)

Interventions

DRUG

Fosigotifator

Oral Use

DRUG

Placebo

Oral Use

Trial Locations (4)

Clinical Neuroscience Solutions - Orlando - East South Street /ID# 265060, Orlando

CenExel CNR /ID# 265866, Sherman Oaks

Northwest Clinical Research Center /ID# 265057, Bellevue

CenExel iResearch, LLC /ID# 265886, Decatur